Stepping through the PR minefield
This article was originally published in Scrip
The pharma industry is no stranger to PR crises, and this month is no exception. As we reported yesterday, the South African health minister has described a planned industry campaign against his country's draft intellectual property law as a "satanic conspiracy".
You may also be interested in...
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.